Oxilight Inc is a biomedical device company that specializes in developing advanced imaging technologies for wound care. The company, founded in 2015, aims to make wound imaging technologies accessible to frontline healthcare professionals. Its vision is to empower frontline healthcare providers to assess wound status anytime and anywhere, including clinics, nursing homes, and patients' homes, enabling earlier diagnostics and triaging of patients with problematic wounds. The company's last investment was a Seed Round investment on 11 May 2018, led by Startupbootcamp Digital Health Chengdu. This investment will likely support Oxilight's mission to revolutionize wound care with its innovative imaging technologies.
No recent news or press coverage available for Oxilight.